Respiratorius is a research company focused on the development of drug candidates for the treatment of cancer and especially aggressive lymphoma. The company was originally established in 1999 as a spin-off from Lund University. The business is located in Sweden, where research is conducted in-house but also through international partners. The company is headquartered in Lund.

Quotes for Respiratorius AB

Right Now

+/-
-0.049
%
-16,33%
Latest
0.251
High
0.35
Low
0.251
Volume
729 180
Turnover (SEK)
199 819
Market Value (MSEK)
73,4
Time (Latest trade)

Board

CEO

  • Johan Drott

Chairperson of the Board

  • Karin Wehlin

Board

  • Anna Törner
  • Johan Drott
  • Kristina Drott

Videos